Introduction to early in vitro identification of metabolites of new chemical entities in drug discovery and development.

The introduction of combinatorial chemistry and robotics for high throughput screening has changed the way drugs are discovered today compared with 10-15 years ago when fewer compounds were tested in animal or organ models. The introduction of new analytical techniques, especially liquid chromatography/mass spectrometry (LC/MS) has made it possible to characterize the chemical properties, permeability, metabolic stability and metabolic fate of a large number of screening hits for further development in a funnel-like manner. The purpose of this contribution is to discuss principles and recent strategies for metabolite identification and to give an introduction to biotransformation studies. Metabolites are experimentally generated with the use of animal and human recombinant expressed enzymes, and different liver and other tissue fractions like microsomes and slices. For separation and identification of structurally diverse metabolites, LC/MS and tandem mass spectrometry (LC/MS/MS) techniques are commonly used. The LC/MS and LC/MS/MS techniques are rapid, sensitive, easy to automate and robust, and therefore, they are the methods of choice for these studies. The outcome of the metabolite identification studies is detection of metabolites that could be pharmacologically active and contribute to the efficacy of a new chemical entity (NCE), and elimination of compounds that form reactive intermediates and/or toxic metabolites that could cause adverse effects of NCE. If such information is available at an early stage during the drug discovery process, the chemical structure of the compound may be modified to reduce the risk of idiosyncratic and/or adverse drug reactions during clinical development.

[1]  R. Ramanathan,et al.  Using mass spectrometry for drug metabolism studies , 2006, Journal of the American Society for Mass Spectrometry.

[2]  Desmond O'Connor,et al.  Accelerated throughput metabolic route screening in early drug discovery using high-resolution liquid chromatography/quadrupole time-of-flight mass spectrometry and automated data analysis. , 2005, Rapid communications in mass spectrometry : RCM.

[3]  F. Guengerich,et al.  Generation of reactive intermediates , 2005, Journal of biochemical and molecular toxicology.

[4]  O. Mcconnell,et al.  Advantages of atmospheric pressure photoionization mass spectrometry in support of drug discovery. , 2005, Rapid communications in mass spectrometry : RCM.

[5]  Hannu Raunio,et al.  Prediction of drug metabolism and interactions on the basis of in vitro investigations. , 2005, Basic & clinical pharmacology & toxicology.

[6]  David Q. Liu,et al.  Strategies for characterization of drug metabolites using liquid chromatography-tandem mass spectrometry in conjunction with chemical derivatization and on-line H/D exchange approaches. , 2005, Journal of pharmaceutical and biomedical analysis.

[7]  I. Kola,et al.  Can the pharmaceutical industry reduce attrition rates? , 2004, Nature Reviews Drug Discovery.

[8]  Helena Idborg,et al.  Multivariate approaches for efficient detection of potential metabolites from liquid chromatography/mass spectrometry data. , 2004, Rapid communications in mass spectrometry : RCM.

[9]  P. Edlund,et al.  Identification of BVT.2938 metabolites by LC/MS and LC/MS/MS after in vitro incubations with liver microsomes and hepatocytes. , 2004, Journal of pharmaceutical and biomedical analysis.

[10]  B. Testa,et al.  Predicting drug metabolism: Concepts and challenges , 2004 .

[11]  T. Baillie.  Chemically Reactive Metabolites in Drug Discovery and Development , 2003 .

[12]  A. Mutlib,et al.  Application of LC/MS, LC/NMR, NMR and Stable Isotopes in Identifying and Characterizing Metabolites , 2003 .

[13]  Manfred Spraul,et al.  LC-NMR-MS in drug discovery. , 2003, Drug discovery today.

[14]  G. Hopfgartner,et al.  Rapid screening and characterization of drug metabolites using a new quadrupole-linear ion trap mass spectrometer. , 2003, Journal of mass spectrometry : JMS.

[15]  M. Pirmohamed,et al.  Are chemically reactive metabolites responsible for adverse reactions to drugs? , 2002, Current drug metabolism.

[16]  J. Uetrecht,et al.  Mechanism of idiosyncratic drug reactions: reactive metabolite formation, protein binding and the regulation of the immune system. , 2002, Current drug metabolism.

[17]  J. Magdalou,et al.  Comparison of electrospray, atmospheric pressure chemical ionization, and atmospheric pressure photoionization in the identification of apomorphine, dobutamine, and entacapone phase II metabolites in biological samples. , 2002, Analytical chemistry.

[18]  G. Dollinger,et al.  Accelerating the drug optimization process: identification, structure elucidation, and quantification of in vivo metabolites using stable isotopes with LC/MSn and the chemiluminescent nitrogen detector. , 2002, Analytical chemistry.

[19]  G. Hopfgartner,et al.  The impact of accurate mass measurements using quadrupole/time-of-flight mass spectrometry on the characterisation and screening , 2000 .

[20]  J Y Zhang,et al.  Pharmacokinetics, tissue distribution, metabolism, and excretion of celecoxib in rats. , 2000, Drug metabolism and disposition: the biological fate of chemicals.

[21]  R. Bible,et al.  Metabolism and Excretion of [14C]Celecoxib in Healthy Male Volunteers , 2000 .

[22]  J. Yuan,et al.  Comparison of celecoxib metabolism and excretion in mouse, rabbit, dog, cynomolgus monkey and rhesus monkey , 2000, Xenobiotica; the fate of foreign compounds in biological systems.

[23]  Shigeo Nakamura,et al.  Effects of Amines on the Formation of Molecular Adduct Ions of Methyl Hydroperoxyoleates in Atmospheric Pressure Chemical Ionization Mass Spectrometry , 1998 .

[24]  G. Dollinger,et al.  Simultaneous On-Line Characterization of Small Organic Molecules Derived from Combinatorial Libraries for Identity, Quantity, and Purity by Reversed-Phase HPLC with Chemiluminescent Nitrogen, UV, and Mass Spectrometric Detection , 1998 .

[25]  Walter A. Korfmacher,et al.  Pharmacokinetic screening for the selection of new drug discovery candidates is greatly enhanced through the use of liquid chromatography-atmospheric pressure ionization tandem mass spectrometry. , 1997, Journal of chromatography. A.

[26]  A. Shevchenko,et al.  Rapid 'de novo' peptide sequencing by a combination of nanoelectrospray, isotopic labeling and a quadrupole/time-of-flight mass spectrometer. , 1997, Rapid communications in mass spectrometry : RCM.

[27]  K. Markides,et al.  Regulation of Multimer Formation in Electrospray Mass Spectrometry , 1996 .

[28]  P. Edlund.  Identification of amperozide metabolites in urine from rats, rabbits, dogs and man by Frit‐FAB LC/MS using deuterated solvents to gain additional structural information , 1995 .

[29]  H. Muenster,et al.  Application of a new atmospheric pressure ionization source for double focusing sector instruments. , 1995, Journal of chromatography. A.

[30]  P. Kebarle,et al.  FROM IONS IN SOLUTION TO IONS IN THE GAS PHASE , 1993 .

[31]  T. Baillie,et al.  Mass spectrometry in the analysis of glutathione conjugates. , 1993, Biological mass spectrometry.

[32]  T. Baillie,et al.  Glutathione: a vehicle for the transport of chemically reactive metabolites in vivo , 1991 .

[33]  John Doull,et al.  Casarett and Doull's toxicology : the basic science of poisons , 2001 .

[34]  J A Miller,et al.  Carcinogenesis by chemicals: an overview--G. H. A. Clowes memorial lecture. , 1970, Cancer research.

[35]  P. Fraser,et al.  Chemical derivatization and mass spectral libraries in metabolic profiling by GC/MS and LC/MS/MS. , 2005, Journal of experimental botany.

[36]  Antony Williams,et al.  Applications of computer software for the interpretation and management of mass spectrometry data in pharmaceutical science. , 2002, Current topics in medicinal chemistry.

[37]  A. Bruins,et al.  Atmospheric pressure photoionization: an ionization method for liquid chromatography-mass spectrometry , 2000, Analytical chemistry.

[38]  R. Bible,et al.  Metabolism and excretion of [(14)C]celecoxib in healthy male volunteers. , 2000, Drug metabolism and disposition: the biological fate of chemicals.

[39]  P N Judson,et al.  Knowledge-based expert systems for toxicity and metabolism prediction: DEREK, StAR and METEOR. , 1999, SAR and QSAR in environmental research.

[40]  A. Dell,et al.  High sensitivity collisionally-activated decomposition tandem mass spectrometry on a novel quadrupole/orthogonal-acceleration time-of-flight mass spectrometer. , 1996, Rapid communications in mass spectrometry : RCM.